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ABSTRACT. Cultured cardiac myocytes from adult Sprague- 
Dawley rats express both insulin-like growth factor-I (IGF-I) 
receptors and insulin-like growth factor-II/mannose 6-phos- 
phate (IGF-II/ManGP) receptors and respond to IGF-I with a 
dose-dependent accumulation of inositol 1,4,5trisphosphate 
[Ins(1,4,5)Ps] and inositol 1,4-bisphosphate [Ins(l,&P& Spe- 
cific bindine of l’2J111GF-I to isolated membranes from cultured 
cardiac my&t& amounted to l-1.2%. Binding of (‘2”I]IGF-I 
was inhibited by unlabeled IGF-I at nanomolar concentrations 
and insulin at much higher concentrations. These data suggest 
that IGF-I binds to its own receptor on rat cardiac myocytes. 
Competitive binding studies using isolated membranes from 
cardiac mvocvtes and I’25111GF-II showed 2-4% specific binding. 
Binding of [‘l’I]IGF-Ii was inhibited by IGF-II-and much less 
potently by IGF-I and insulin. Immunoglobulin G (IgG) 3637 
(an IgG directed against the IGF-II/ManGP receptor) partially 
inhibited binding of [‘261]IGF-II whereas nonimmune IgG did 
not. Affinity cross-linking studies with [1251]IGF-II and cardiac 
myocyte membranes and subsequent analysis of the ligand- 
receptor complex using SDS-PAGE and autoradiography 
showed a radiolabeled band of approximately 250 kilodalton 
(kDa). The formation of the [‘251]IGF-II-receptor complex was 
inhibited by incubation with IGF-II and IgG 3637 but not by 
insulin or nonimmune IgG. 
Western blotting of protein extracts from cultured cardiac 
myocytes was performed using IgG 3637 and an immunoperox- 
idase technique for the visualization of the IGF-II/ManGP re- 
ceptor protein. A specific band at 220 kDa under nonreducing 
conditions was detected on the blots, providing further evidence 
for the expression of the IGF-II/ManGP receptor by cardiac 
myocytes. 
The effect of IGFs on the accumulation of inositol phosphates 
was measured by HPLC analysis of perchloric acid extracts from 
myo-[3H]inositol-labeled cultured cardiac myocytes. IGF-I (50 
rig/ml) stimulated the accumulation both of Ins(1,4,5)PR and 
Ins(1,4)Pz after 30 set by 43% and 63%. IGF-II (up to 500 ng/ 
ml) had no significant effect on inositol phosphate accumulation 
under the same conditions. However, in the presence of milli- 
molar concentrations of ManGP, IGF-II (500 rig/ml) also in- 
creased Ins(1,4,5)P3 accumulation by 59%. We conclude that 
cardiac myocytes from adult rats express IGF receptors and 
respond to IGFs with the accumulation of Ins(1,4,5)P, and 
Ins(l,4)P2. This effect seems to be mediated by an IGF-I recep- 
tor-specific pathway. (Endocrinology 130: 145-151,1992) 
T HE insulin-like growth factors (IGF-I and IGF-II) are polypeptide hormones closely related to insulin 
in regard to their amino acid sequence and biological 
activity (1, 2). IGF-I mediates the anabolic action of GH 
in uiuo. The in uiuo role of IGF-II is less clear. The IGFs 
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bind to high affinity receptors present on many cells and 
in many tissues (3). The IGF-I receptor is a heterotetra- 
mer, made of two a-binding subunits [(130 kilodaltons 
kDa)] and two P-subunits (95 kDa) which contain tyro- 
sine kinase activity. The IGF-I receptor is highly homol- 
ogous to the insulin receptor and is thought to mediate 
the biological effect of both IGF-I and IGF-II (3,4). The 
primary structure of the IGF-II receptor was shown by 
complementary DNA cloning to be identical to the struc- 
ture of the cation-independent mannose 6-phosphate 
receptor (ManGP) (5-9). It is clear that this receptor 
targets acid hydrolases to lysosomes and also serves as a 
degradative pathway for IGF-II (10-13). It has also been 
suggested that the IGF-II/ManGP receptor functions as 
a signaling receptor for IGF-II mediated biological ac- 
tions such as stimulation of DNA-synthesis and cell 
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proliferation in BALB/c 3T3 cells (14,15), clonal growth 
of K562 erythroleukemia cells (16), Na+/H+-exchange in 
proximal tubular cells from canine kidney (17), stimula- 
tion of glycogen synthesis in a human hepatoma cell line 
(Hep 62) (18). In addition, IGF-II has also been impli- 
cated in modulating lysosomal enzyme trafficking via the 
IGF-II/ManGP receptor (19, 20). 
IGF receptors have been found in heart tissue (21, 22) 
and a positive inotropic effect of insulin and both IGF-I 
and IGF-II on isolated fetal rat cardiac myocytes has 
been described (23). 
For many other agonists which elicit positive inotropic 
responses specific receptors have been found in mam- 
malian heart. In addition, the release of inositol 1,4,5- 
trisphosphate [Ins(1,4,5)P3] as an initial event in recep- 
tor-mediated activation of myocardial phosphoinositi- 
dase C has been described for a number of such receptors, 
for example the cui-adrenoceptor (24), the purinoceptor 
P2 (25), and the histamine H1 receptor (26). 
Although the physiological responses to IGFs are well 
described in several cell types, the signal transduction 
mechanisms by which IGF-I and IGF-II transmit their 
cellular signal remain to be elucidated (27). 
Contradictory data about the effects of IGFs on ino- 
sit01 trisphosphate generation (28-30) prompted us to 
investigate 1) the presence and binding characteristics 
of the IGF-I- and the IGF-II/ManGP-receptor and, 2) 
the effects of IGF-I and IGF-II on inositol polyphosphate 
accumulation in cultured cardiac myocytes. 
Rat cardiac myocytes were chosen as a model since 1) 
InsPs accumulation can be studied directly in a defined 
primary culture system of a homogenous cell population, 
and 2) such cells have been reported to respond to IGFs 
GO. 
Materials and Methods 
Cell culture, myo-fH]inositol labeling and stimulation 
experiments 
The procedure of isolating cardiac myocytes from adult Spra- 
gue-Dawley rats (lo-14 weeks old, obtained from the Zentral- 
institut fiir Versuchstierzucht, Hannover, Germany) was car- 
ried out ss described recently (31). The use of the animals was 
approved by the Freie und Hansestadt Hamburg, Gesundheits- 
behorde. In brief, hearts were removed and perfused in a 
recirculating manner for 30 min with 60 ml Krebs-Ringer- 
bicarbonate buffer containing 5500 U collagenase (type II, 
Biochrom, Berlin, Germany). Then atria were removed and the 
ventricles were cut in 20 ml Krebs-Ringer-bicarbonate buffer 
containing 2750 U collagenase. Rod-shaped cardiomyocytes 
were obtained by two centrifugation steps (20 x g, 60 set). The 
Ca’+-concentration was raised in 10 steps up to 0.5 mM, fol- 
lowed by another centrifugation step (20 x g, 60 set). The 
myocytee were then incubated for 2 h in medium 199 (Bioch- 
rom) containing fetal calf serum (4%), gentamycin, and 1.8 mM 
Ca++. Nonadherent cells were removed and the rod-shaped 
myocytes were labeled for 6 h in serum-free medium 199 con- 
. 
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taining myo-[“Hlinositol (20 rCi/ml, SA, 60-120 Ci/mmol). 
After labeling, the myocytes were incubated in Krebs-Ringer- 
HEPES buffer containing 10 mM LiCl (and 10 ELM propranolol 
when (-)-noradrenaline was used for stimulation) and then 
exposed to IGFs, (-) -noradrenaline, or carbamoylcholine for 
30 sec. The incubation was terminated by addition of HClO, 
(lo%, vol/vol). Samples were transferred to Eppendorf tubes, 
precipitated protein was removed by centrifugation (10,000 X 
g, 10 min), and the supernatants were titrated to pH 4 to 5. 
KClO, was removed by centrifugation (10,000 X g, 10 min) and 
the supernatants were subjected to HPLC analysis. 
HPLC analysis of inositol phosphates 
Inositol phosphates were separated by anion exchange- 
HPLC using a Merck-Hitachi LC-5000 liquid controller and a 
L-6000 pump equipped with a Partisil 10 SAX column (What- 
man, Clifton, NJ) by a method originally introduced by Dean 
and Moyer (32). The method was modified to elute InsP4 from 
the column as described recently (24). Quantitation of inositol 
phosphate accumulation was carried out by liquid scintillation 
counting (Packard TriCarb 460, Frankfurt, Germany) of 1 ml 
or 0.5 ml fractions mixed with 5 ml or 2.5 ml Ready Value 
scintillation cocktail (Beckman, Munchen, Germany) for 9 min 
or 30 min. These long counting times were necessary to obtain 
reliable data from samples with low radioactivity. 
Preparation of cardiomyocyte membranes 
Cardiac myocytes from one rat heart were homogenized in 2 
ml membrane isolation buffer (10 mM HEPES, 230 mM man- 
nitol, 70 mM sucrose, 50 rig/ml phenylmethylsulfonylfluoride, 
50 rig/ml antipain, pH 7.0) by 10 strokes of a glass/teflon- 
homogenizer. Crude membranes were prepared by two centrif- 
ugation steps: removal of cell fragments and nuclei at 1000 X g 
(10 min, 4 C) and separation of the cytosolic fraction from the 
total membrane fraction at 100,000 X g (60 min, 4 C, Kontron 
centrifuge T-2060). 
Solubilization of IGF-II/Mar&P-receptors 
Cultured myocytes were treated with Tris buffer containing 
20 mM Tris-HCl, pH 7.4, 2% (vol/vol) Triton X-100, 50 rig/ml 
phenylmethylsulfonylfluoride, 50 rig/ml antipain (about 1 ml/ 
2.4 x lo6 cells) for 30 min at 4 C. The lysate was harvested 
with a rubber policeman and transferred to Eppendorf tubes 
and stored frozen at -20 C. 
Polyacrylamide gel electrophoresis (PAGE) 
Sodium dodecyl sulfate (SDS)-PAGE was performed using 
the discontinuous buffer system of Laemmli (6% acrylamide- 
bis) (33). 
Antireceptor antibody 
Antiserum 3637 has been raised against IGF-II receptor that 
had been purified from Swarm rat chondrosarcoma cells by 
affinity chromatography on IGF-II sepharose (13). The anti- 
body is specific for rat IGF-II/ManGP receptor and does neither 
recognize the IGF-I or insulin receptor nor the IGF binding 
proteins (13, 34). Also, antibody 3637 does not recognize the 
cation-dependent 46 kDa Man6P receptor (35). 
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Western blotting of IGF-II/ManGP receptors 
The Western blotting procedure was essentially performed 
as described previously (13). In brief, cardiac myocytes were 
solubilized and subjected to SDS-PAGE (6% gel) under non- 
reducing conditions. The proteins were transferred onto nitro- 
cellulose paper by electroelution and the nitrocellulose sheets 
incubated with antiserum 3637. Antirabbit-immunoglobulin G 
(IgG) antiserum and a biotin-avidin horse radish peroxidase 
system (Vectastain) were used to detect receptor-antibody com- 
plexes on the nitrocellulose sheets. 
Binding of j’26Z]IGF-I and ~z”I]IGF-II to cardiomyocyte 
membranes 
Binding of [‘251]IGF-I and [“‘I]IGF-11 to cardiomyocyte 
membranes (0.65 mg membrane protein/400 ~1) was carried out 
in 1.6 ml microfuge tubes for 2 h at room temperature in 
Dulbecco’s modified Eagle’s medium (DMEM) with 0.2% BSA 
with labeled and unlabeled peptides or I&s present as indi- 
cated. Bound from free radioactivity was separated by centrif- 
ugation in a Hettich microfuge. 
Affinity cross-linking of f’251]IGF-II to cardiomyocyte 
membranes 
Affinity cross-linking was carried out using disuccinimidyl 
suberate (DSS) as the cross-linking reagent (Pierce Chemicals, 
Rockford, IL). Crude membranes from rat cardiac myocytes 
were incubated with radioligands, unlabeled polypeptides, and 
IgGs as indicated for 2 h at room temperature in DMEM with 
1% BSA. The membranes were centrifuged, washed once with 
cold PBS, pH 7.4, and resuspended in DMEM with 0.1 mM 
DSS without BSA. After 10 min at room temperature, the 
reaction was quenched with 10 mM Tris, 1 mM EDTA solution 
for 5 min at room temperature, the samples were centrifuged 
in a microfuge for 3 min, and the liquid was discarded. Sample 
buffer was added, and the samples were boiled for 3 min and 
analyzed by SDS-PAGE (0.1% SDS, 6% acrylamide) and sub- 
sequent autoradiography (Kodak X-Omat film). 
MaterMLs 
Recombinant human IGF-I and IGF-II were a kind gift from 
Dr. K. Miiller, Ciba Geigy (Basel, Switzerland) or donated by 
Eli Lilly (Indianapolis, IN). Rat IGF-II (MSA-111-2) was kindly 
given by Dr. S. P. Nissley, National Institutes of Health (Be- 
thesda, MD). Insulin and mannose 6-phosphate were purchased 
from Sigma Biochemicals (Taufkirchen, Germany). IGF-II was 
radioiodinated by a modified chloramine-T procedure to spe- 
cific activities of 50-100 Ci/g (36). [1251]IGF-I (SA, 2000 Ci/ 
mmol) was purchased from Amersham Buchler (Braunschweig, 
Germany). 
All other materials were obtained as described in an earlier 
paper (31). 
Results 
Rat cardiac myocytes express high affinity binding sites 
for r261]IGF-I and P251]IGF-II 
Competitive binding studies using crude membranes 
from isolated rat cardiac myocytes and [‘251]IGF-I 
showed l-1.2% specific binding. Half-maximal displace- 
ment of [‘251]IGF-I binding occurred at approximately 
1.5 rig/ml at a membrane protein concentration of 2.125 
mg/ml. Insulin at high concentrations (5-25 pg/ml) also 
completely blocked binding of [‘2SI]IGF-I to rat cardiac 
myocyte membranes. This result strongly suggests bind- 
ing of [‘251]IGF-I to the IGF-I receptor present on cardiac 
myocytes of adult rat hearts (Fig. 1A). 
Competitive binding studies using crude membranes 
from isolated cardiac myocytes and [‘251]IGF-II showed 
2-4% specific binding. Half-maximal displacement of 
[1251]IGF-II binding occurred at 30 rig/ml IGF-II at a 
membrane protein concentration of 2.125 mg/ml (Fig. 
1B). IGF-I was much less potent, anti IGF-II/ManGP 
receptor IgG competed partially, whereas nonimmune 
rabbit IgG was less effective (data not shown). Interest- 
ingly, insulin at high concentrations (5-25 hg/ml) also 
displaced [‘261]IGF-II binding partially (data not shown). 
These results suggest that [‘251]IGF-II under the condi- 
tions of these experiments might bind both to the IGF- 
II/ManGP receptor (IgG 3637 competable site) and the 
IGF-I receptor (insulin competable site). 
Affinity cross-linking experiments were performed us- 
ing cardiomyocyte membranes, [‘251]IGF-II and DSS 
suberate as the cross-linking agent. Analysis of ligand- 
receptor complexes by SDS-PAGE and autoradiography 
was carried out as described in Materials and Methods. 
&---- 0 15 35 75 30 125 500 U-I [nq/mi] 
5 25 insulin [us/ml] 
1300 
8 
Ts 
a1100 - 
0 
s 
2 900 
zz 
I 
2 
z 700 - 
" 
5ooL 4 
0 1.5 3.5 7.5 30 125 500 
,Gi-'1 :ng/mij 
FIG. 1. Binding of (““IJIGF-I and [‘251]IGF-II to crude membranes 
from isolated cardiac myocytes. A, [‘251]IGF-I was incubated with 
cardiac myocyte membranes (0.85 mg membrane protein/400 91) in the 
presence of various concentrations of unlabeled IGF-I or insulin for 2.5 
h as described in Materials and Methods. B, [‘2”I]IGF-II was incubated 
with cardiac myocyte membranes (0.85 mg membrane protein/400 ~1) 
in the presence of various concentrations of unlabeled IGF-II for 2.5 h 
as described in Materials and Methods. Data are mean values + SD 
from three independent experiments. 
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A specific band with an approximate mol wt of 250 k 
under reducing conditions was detected. IGF-II (2 pg/ 
ml) and IgG 3637 (180 pg/ml) completely abolished the 
formation of this band whereas nonimmune IgG and 
insulin did not (Fig. 2A). We conclude from these data 
that cardiac myocytes express IGF-II/ManGP receptors. 
Further evidence for the presence of IGF-II/ManGP re- 
ceptors on cardiac myocytes is derived from Western 
blotting of the IGF-II/ManGP receptor in protein ex- 
tracts from cultured cardiac myocytes. A specific band 
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FIG. 2. Top, Affinity cross-linking of [‘*“I]IGF-II to rat cardiomyocyte 
membranes. [‘261]IGF-II was incubated with crude membranes from 
isolated cardiac myocytes, and DSS was used as the cross-linking 
reagent as described in Mate&& and Methods in the absence (lane A) 
or presence (lane B) of 2 pg/ml IGF-II, and in the presence of 180 pg/ 
ml IgG 3637 (lane C), 166 rg/mI nonimmune IgG (lane D), or 25 fig/ 
ml insulin (lane E). Bottom, Western blotting of the solubilized IGF- 
II/ManGP receptor from cultured rat cardiac myocytes. Western blot- 
ting of IGF-II/ManGP receptors was performed as described in Mate- 
riols and Methods. In brief, solubilized extracts from cultured cardiac 
myocytes (lanes A-G) and extracts from rat liver (lane LI) and rat 
lung (lane LU) were subjected to SDS-PAGE under nonreducing con- 
ditions. Proteins were then transferred onto nitrocellulose paper and 
incubated with antiserum 3637. Antirabbit-IgG antiserum and a biotin- 
avidin horse raddish peroxidase system were used to detect receptor- 
antibody complexes. Protein bands of lower molecular weights were 
also seen when nonimmune rabbit serum was used instead of antiserum 
3637 and therefore represent nonspecifically stained proteins. One 
representative blot out of three independent experiments is shown. 
with an apparent mol mass of 220 k under nonreducing 
conditions was detected in all protein extracts [seven 
different protein preparations from three independent 
cardiac myocyte preparations (Fig. 2B)]. The protein 
bands at about 72 to 80 kDa were also seen when non- 
immune rabbit serum was used instead of antiserum 
3637, indicating a nonspecific interaction with the detec- 
tion system rather than receptor degradation products. 
IGFs stimulate inositol polyphosphute accumulation in 
cardiac myocytes 
Inositol phosphates were measured after stimulation 
of cardiac myocytes with IGFs, (-)-noradrenaline, car- 
bamoylcholine, or IGF-II in combination with Man6P as 
described in Materiakr and Methods. Stimulation of cul- 
tured cardiac myocytes with nanomolar concentrations 
of IGF-I for 30 set resulted in a significant increase both 
in Ins( 1,4,5)P3 and inositol1,4-bisphosphate [Ins( 1,4)Pz] 
indicating rapid activation of phosphoinositidase C as 
well as rapid degradation of Ins(1,4,5)P3 by Ei-phos- 
phomonoesterase activity (Fig. 3). Other inositol phos- 
phate compounds, in particular intermediates of the 
inositol tetrakisphosphate pathway such as Ins( 1,3,4,5)P4, 
Ins( 1,3,4)P3, Ins( 1,3)P2, and Ins(3,4)Pz were not affected 
by IGF-I during the early stimulation period (data not 
shown). 
IGF-II was used for stimulation alone or in combina- 
tion with Man6P as it was recently reported (29) that 
Man6P enhances the IGF-II-mediated activation of 
phosphoinositidase C. Even high concentrations of IGF- 
II (500 rig/ml) had no significant stimulatory effect on 
inositol phosphate accumulation after 30 set (Fig. 3). 
Interestingly, when IGF-II (250 rig/ml or 500 rig/ml) was 
added in the presence of Man6P (5 mM), a significant 
increase of Ins(1,4,5)P3 was observed (Fig. 3). Neither 
the direct phosphorylation or dephosphorylation prod- 
ucts of Ins(1,4,5)P3, InsP1, and Ins(l,4)P2 (Fig. 3), nor 
any other known inositol phosphates (data not shown) 
were found to be elevated within 30 set of IGF-II or 
combined IGF-II/ManGP-treatment of cardiac myocytes. 
Man6P at millimolar concentrations had no effect on 
Ins(1,4,5)P3 accumulation when tested alone. 
Stimulation of inositol phosphate accumulation by 
pharmacological agents via al-adrenergic and muscarinic 
cholinergic receptors, which are coupled to cardiac phos- 
phoinositidase C, induced a more pronounced effect on 
inositol polyphosphate accumulation than IGF-I or IGF- 
II/ManGP (Table 1). In particular q-adrenergic stimu- 
lation by 50 PM (-)-noradrenaline (in the presence of 10 
PM propranolol) provoked an approximately lo-fold 
higher Ins(1,4,5)P3 release when compared with the stim- 
ulatory effect of nanomolar concentrations of IGF-I. 
Discussion 
It has been suggested in the literature that IGF recep- 
tors are present in rat heart (21, 22). We demonstrate 
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FIG. 3. Effect of IGFs on inositol polyphosphate accumulation in rat 
cardiac myocytes. Cardiac myocytes were cultured and prelabeled with 
myo-[aH]inositol as described in Materi& and Methods. Stimulation 
of cells with IGF-I (0), IGF-II (0), or IGF-II in combination with 
Man6P (5 mM; 0) was carried out in KRH-buffer at 38 C for 30 sec. 
Neutralized perchloric acid extracts were analyzed for inositol phos- 
phates by HPLC. Values are presented as mean + SD. (n = 3-5). 
Radioactivity of inositol phosphates in samples from unstimulated cells 
was (in desentegrations per min/106 cells): Ins(1,4,5)P3 180, InsP( 24, 
Ins(l,4)Pz 420. Usually, 3-3.5 X 10 cells were plated on one culture 
dish and extracts from three to four dishes were pooled for analysis. 
The liquid counting efficiency ranged between 30% and 40% depending 
on the salt content of the samples. For an accurate quantification of 
radioactivity long counting periods were chosen, e.g. 3 X 3 min or 3 X 
10 min/sample. Arrows indicate significant differences from control 
values according to analysis of variance (multifactor analysis of vari- 
ance, P I 0.05). 
here that both IGF-I receptors and IGF-II/ManGP recep- 
tors in rat heart are actually expressed by cardiac myo- 
cytes. 
Sklar et al. (21) using total protein lysates from rat 
hearts and immunoblotting demonstrated the expression 
of IGF-II/ManGP receptors in rat hearts at different 
ages. Engelmann et al. (22) used total membrane prepa- 
rations from adult rat hearts and binding and affinity 
TABLE 1. Effect of various agonists on inositol phosphate accumula- 
tion in rat cardiac myocytes 
Ins(1,4,5)P3 InsPI Ins(l,4)Pn 
(fold stimulation of control) 
Control 1.00 + 0.18 1.00 + 0.50 1.00 + 0.17 
IGF-I (50 rig/ml) 1.48 k 0.21” 1.08 k 0.28 1.64 + 0.36” 
IGF-II (500 rig/ml) 1.34 rt 0.20 1.10 + 0.03 1.09 + 0.26 
IGF-II/ManGP (500 ng/ 1.59 k 0.27” 0.97 + 0.04 1.19 + 0.52 
ml, 5 mh4) 
Noradrenaline (50 pM) 6.19 + 1.19’ 10.06 It 0.97’ 7.10 zt 1.32’ 
(+ propranolol 10 pM) 
Carbachol(lO0 PM) 1.99 rt 0.42’ 4.92 + 1.74b 1.78 + 0.25b 
Cardiac myocytes were cultured and prelabeled with myo-[“H]ino- 
sitol as described in Materials and Methods. Stimulation was carried 
out in KRH-buffer at 38 C for 30 sec. Neutralized perchloric acid 
extracts were analyzed for inositol phosphates by HPLC. Values are 
presented as mean k SD (n = 4-9). Radioactivity of inositol phosphates 
in samples from unstimulated cells was (in disintegration per min/106 
cells): Ins(1,4,5)P3 180, InsP, 24, Ins(l,4)P;! 420. 
’ Significant differences to control values according to analysis of 
variance (multifactor analysis of variance, P 1. 0.05). 
b P 50.01. 
cross-linking studies to conclude that IGF-I receptors 
are present in rat heart. The cultured cardiac myocytes 
used in our experiments are homogenous preparations 
with 5 & 1.8% (n = 6) of contaminating cells (Gercken, 
G., and Achterberg, V., unpublished results). Taking into 
account that the myocyte content of the whole heart is 
only some 12% of the total number of cells (37), the use 
of an about 95% pure population means a great improve- 
ment compared to conventional models, e.g. whole heart 
preparations or papillary muscles. Using membranes 
from such cardiac myocytes, we found that both [1251] 
IGF-I and [‘251]IGF-II bind to specific high affinity bind- 
ing sites with the binding characteristics of the IGF-I 
and the IGF-II/ManGP receptor respectively. Our affin- 
ity cross-linking and immunoblotting data further con- 
firm the presence of the IGF-II/ManGP receptor on adult 
rat cardiac myocytes. Most importantly our findings 
indicate not only the presence of the IGF receptors on 
cardiac myocytes, but also that the IGF-I receptor might 
actually be coupled to phosphoinositidase C in these 
highly differentiated cells. Stimulation of cardiac myo- 
cytes with nanomolar concentrations of IGF-I led to a 
significant increase of Ins(1,4,5)P3 and Ins(1,4)P2. Other 
inositol phosphorylation or dephosphorylation products 
were not affected by stimulation of cells with IGF-I. The 
finding that the IGF-I receptor is linked to phosphoinos- 
itidase C is consistent with a very recent report from 
Takasu et al. (38). These authors found a dose-dependent 
effect of IGF-I (ECBO = 10 rig/ml) on inositol trisphos- 
phate formation and Ca++-release in cultured porcine 
thyroid cells. In contrast to the finding of Takasu et al. 
in thyroid cells (38), we could not detect a marked 
increase in inositoi monophosphate (InsPI) after treat- 
ment with IGF-I in cardiac myocytes. This discrepancy 
may be due to the different incubation periods used. 
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Increased accumulation of InsPI in cardiac myocytes was 
observed only after 15 min of muscarinic cholinergic 
stimulation (31). Therefore it seems unlikely that IGF- 
I, which exerts a weaker effect than carbamoylcholine in 
cardiac myocytes, leads to a significant increase of InsPI 
after 30 sec. Alternatively, IGF-I might elucidate distinct 
effects on the accumulation of inositol phosphates in 
different cell systems. 
It has been reported in the literature that IGF-I in- 
duces a positive inotropic effect in cardiac myocytes (23). 
The concentration of IGF-I needed for maximal inotropic 
effects in the study by Vetter et al. (23) are in the same 
range as the concentrations of IGF-I needed to induce 
inositol phosphate accumulation in our study. Stimula- 
tion of other myocardial receptors such as the cul-adre- 
noceptor (24, 39), the histamine receptor H1 (26), and 
the purinoceptor Pz (25) resulted in phosphoinositidase 
C activation as well as in an increase in force of contrac- 
tion. Thus, it might well be that IGF-I exerts a positive 
inotropic effect in cardiac myocytes via a phosphoinosi- 
tidase C-mediated second messenger pathway. Although 
the increase of Ins(1,4,5)P3 was markedly lower after 
IGF- than after ai-adrenergic- or muscarinic cholinergic 
stimulation in cardiac myocytes, it should be mentioned, 
that for these studies (24, 31) pharmacological agents at 
very high concentrations have been used. Therefore it 
appears unlikely that physiological concentrations of 
IGFs would exert the same increases in inositol phos- 
phates. This suggestion is further supported by the find- 
ing that stimulation of ai-adrenoceptors without /3-adre- 
noceptor blockade (an experimental design that mimics 
a more physiological situation) resulted in a markedly 
diminished increase in all inositol phosphates in cardiac 
myocytes (Guse, A. H., I. Berg, and G. Gercken, in press). 
IGF-II, in the presence of millimolar concentrations 
of Man6P seems to mediate its, albeit weak, effect on 
inositol phosphate formation via the IGF-I receptor as 
is suggested by the high concentration needed. Many 
other biological effects of IGF-II are also thought to be 
mediated via the IGF-I receptor (13, 40). In renal proxi- 
mal tubular membranes, to our knowledge the only sys- 
tem where IGF-II-induced Ins( 1,4,5)P3 formation was 
observed, a 3- to 4-fold increase of Ins(1,4,5)P3 was 
measured after stimulation with lo-’ M IGF-II (-7 ng/ 
ml), whereas IGF-I even at micromolar concentrations 
had no effect (28). In cardiac myocytes, we were unable 
to provoke any effect on inositol phosphate accumulation 
at such low concentrations of IGF-II (data not shown). 
Interestingly, in a second report Rogers and Hammer- 
man (29) showed that millimolar concentrations of 
Man6P enhanced IGF-II-induced Ins( 1,4,5)P3-formation 
in proximal tubular membranes. Man6P also increased 
the binding of IGF-II to the IGF-II/ManGP receptor in 
several cell systems (19, 29, 41, 42). However, the stim- 
ulatory effect of Man6P is not a universal finding and 
seems to depend upon the ligand and the system studied 
(7, 43, 44). It is possible that millimolar concentrations 
of Man6P may have modulated the amount of IGF-II 
available for binding to the effective receptor system 
resulting in the leftwardshift of the dose-response curve 
for IGF-II in our as well as in Rogers and Hammerman’s 
study (29). 
Finally, in another recent study Thrakker et al. (30) 
reported that in isolated human hepatocytes IGF-I, IGF- 
II, and insulin had no stimulatory effect on inositol 
phosphate accumulation. This lack of effect of IGFs may 
potentially be explained by the method used for meas- 
uring the inositol phosphate response. Thrakker et al. 
(30) counted an aliquot from the trichloroacetic super- 
natant of hepatocyte lysates without any separation of 
inositol from the inositol phosphates. Thus, most of the 
radioactivity measured in their study might have been 
[3H]inositol and only a minor part represented [“HI 
inositol phosphates. Small changes in inositol phosphate 
accumulation, especially those of Ins( 1,4,5)P3 could not 
have been detected in such a system. 
In conclusion, our results indicate not only the pres- 
ence of IGF receptors on cardiac myocytes, but also 
evidence the linkage of the IGF-I receptor to the inositol 
phosphate system. 
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